Functionalization of lipid nanoemulsions with humanized antibodies using plug-and-play cholesterol anchor for targeting cancer cells
Lipid nanoemulsions (NEs) are promising green nanocarriers for diagnostic and therapeutic applications, but their functionalization with biomolecules, such as antibodies, remains a challenge due to liquid nature of their core. Here, we developed an original plug-and-play strategy to graft an antibody (trastuzumab) at the surface of NEs, using components generally recognized as safe (GRAS). We synthesized a reactive 4-nitrophenyl carbonate of cholesterol (NPC-Chol) and a Biotin-PEG<sub>3000</sub>-Lysine linker, which can react within one-pot formulation to form an amphiphilic carbamate Biotin-PEG<sub>3000</sub>-Cholesterol. The cholesterol ensures anchorage of the linker, which effectively exposes biotin moiety at the surface of NEs for further antibody grafting using a biotin-neutravidin coupling. The reaction between the Biotin-PEG<sub>3000</sub>-Lysine linker and NPC-Chol was confirmed by <sup>1</sup>H-NMR and absorption spectroscopy. The obtained biotinylated 50-nm NEs loaded with a near-infrared dye were successfully targeted to neutravidin-coated glass surfaces and imaged at the single-droplet level. The biotinylated NEs bearing the trastuzumab antibody targeted specifically HER2-amplified breast cancer models HCC-1954 and SKBR3, in contrast to control MDA-MB-231 (HER2-low) cells. Altogether, our study proposes an efficient methodology for grafting antibodies to the surface of NEs, which offers new opportunities of application of these green nanocarriers in biomedicine.
Authors
- Nicolas Anton (ORCID: https://orcid.org/0000-0002-7047-9657)
- Jacky G. Goetz (ORCID: https://orcid.org/0000-0003-2842-8116)
- Vincent Mittelheisser (ORCID: https://orcid.org/0000-0002-0456-3957)
- Bohdan Andreiuk (ORCID: https://orcid.org/0000-0001-6844-5733)
- Olivier Lefèbvre (ORCID: https://orcid.org/0000-0001-9130-9174)
- Andrey S. Klymchenko (ORCID: https://orcid.org/0000-0002-2423-830X)
- Valeria Jose Boide-Trujillo
- Fei Liu (ORCID: https://orcid.org/0000-0003-0064-7827)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Regenerative NanoMedicine (FR)
- Laboratoire de Biophotonique et Pharmacologie (FR)
- La Ligue Contre le Cancer (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Nanoscale Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5na00606f
- Citations
- 2
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.19
Funders
- Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Université de Strasbourg
- Ligue Contre le Cancer
- China Scholarship Council
- Institut National Du Cancer
- National Cancer Institute